Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response
NCT ID: NCT03141606
Last Updated: 2019-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
230 participants
OBSERVATIONAL
2016-04-30
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients
NCT05078125
R Wave Sensing After VT Ablation
NCT03779165
Left Atrial Volume and Function in Children Assessed by Echo 3DRT: Reference Values for Normal Children
NCT01481415
Concealed Myocardial Abnormalities by Cardiac Magnetic Resonance Imaging in Idiopathic VT
NCT06146556
Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy
NCT06730464
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with standard indication to CRT according current guideline, sinus rhythm at implantation, LBBB and QRS duration \>= 120 ms
* Patients who will undergo to a new CRT-defibrillator system implantation
* Patients who are able to understand and sign the informed consent
* Patients who are able to attend all required follow-up visits at the study centerfor 24 months
Exclusion Criteria
* Women who are pregnant or who are planning to become pregnant
* Patients with permanent Atrial Fibrillation or persistent Atrial Fibrillation in the 90 days preceding the implantation
* Patients with organic mitral valve disease
* Patients with prosthetic heart valves
* Patients who will undergo to upgrading from other devices (PM or ICD) to CRT, heart transplantation, patients with CRT devices
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Borgo Trento - Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Giovanni Morani
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
G. Panico Hospital
Tricase, Italy/Lecce, Italy
Borgo Trento Hospital
Verona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20140002277
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.